GSK3B and Alzheimer disease: It was found that AME can improve neuronal dysfunction induced by Aβ1-42 in rats and inhibit NLRP3 inflammasome-induced pyroptosis by regulating AMPK/GSK-3-β signaling, thereby ameliorating the neurotoxicity caused by Aβ1-42 in AD (Zhao et al., 2019).